Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma

被引：0
|
作者：
David T Yang
Ken H Young
Brad S Kahl
Stephanie Markovina
Shigeki Miyamoto
机构：
[1] University of Wisconsin School of Medicine and Public Health,Department of Pharmacology
[2] University of Wisconsin School of Medicine and Public Health,Department of Pathology and Laboratory Medicine
[3] University of Wisconsin School of Medicine and Public Health,Department of Medicine
[4] University of Wisconsin,Paul P. Carbone Comprehensive Cancer Center
[5] University of Wisconsin School of Medicine and Public Health,Program in Cellular and Molecular Biology and Medical Scientist Training Program
来源：
Molecular Cancer | / 7卷
关键词：
Bortezomib; Electrophoretic Mobility Shift Assay; Mantle Cell Lymphoma; Combination Index; Perillyl Alcohol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Regulation of Mcl-1 by constitutive activation of NF-kappaB contributes to cell viability in human esophageal squamous cell carcinoma cells
    Liu, Haidan
    Yang, Jinfu
    Yuan, Yunchang
    Xia, Zhenkun
    Chen, Mingjiu
    Xie, Li
    Ma, Xiaolong
    Wang, Jian
    Ouyang, Sufeng
    Wu, Qin
    Yu, Fenglei
    Zhou, Xinmin
    Yang, Yifeng
    Cao, Ya
    Hu, Jianguo
    Yin, Bangliang
    BMC CANCER, 2014, 14
  • [32] Regulation of Mcl-1 by constitutive activation of NF-kappaB contributes to cell viability in human esophageal squamous cell carcinoma cells
    Haidan Liu
    Jinfu Yang
    Yunchang Yuan
    Zhenkun Xia
    Mingjiu Chen
    Li Xie
    Xiaolong Ma
    Jian Wang
    Sufeng Ouyang
    Qin Wu
    Fenglei Yu
    Xinmin Zhou
    Yifeng Yang
    Ya Cao
    Jianguo Hu
    Bangliang Yin
    BMC Cancer, 14
  • [33] Cell autonomous expression of inflammatory genes in biologically aged fibroblasts associated with elevated NF-kappaB activity
    Kriete A.
    Mayo K.L.
    Yalamanchili N.
    Beggs W.
    Bender P.
    Kari C.
    Rodeck U.
    Immunity & Ageing, 5 (1)
  • [34] Activity of bortezomib in mantle cell lymphoma, diffuse large B cell, and small lymphocytic lymphoma.
    Fauble, Veena S.
    Lobocki, Catherine
    Eapen, Amy
    Terebelo, Howard R.
    BLOOD, 2006, 108 (11) : 252B - 252B
  • [35] Is bortezomib active in patients with mantle cell lymphoma?
    Ludwig, Heinz
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (05): : 276 - 277
  • [36] Bortezomib for the treatment of mantle cell lymphoma: an update
    Hambley, Bryan
    Caimi, Paolo F.
    William, Basem M.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (04) : 196 - 208
  • [37] Is bortezomib active in patients with mantle cell lymphoma?
    Heinz Ludwig
    Nature Clinical Practice Oncology, 2007, 4 : 276 - 277
  • [38] ESTABLISHMENT OF A BORTEZOMIB-RESISTANT CELL LINE KM3/BTZ
    Yedi, P.
    Luqun, W.
    HAEMATOLOGICA, 2013, 98 : 594 - 594
  • [39] Cytotoxicity and Anti-inflammatory Activity of Flavonoid Derivatives Targeting NF-kappaB
    Naik, Kamlesh K.
    Thangavel, Sivakumar
    Alam, Afroze
    RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2016, 10 (02) : 119 - 132
  • [40] GSK-3β controls NF-kappaB activity via IKKγ/NEMO
    Senad Medunjanin
    Lisa Schleithoff
    Christian Fiegehenn
    Soenke Weinert
    Werner Zuschratter
    Ruediger C. Braun-Dullaeus
    Scientific Reports, 6
12345